The Immune Inductive Role of Hepatic Arterial Infusion Chemotherapy Prior to Atezolizumab Plus Bevacizumab Combination Therapy in Hepatocellular Carcinoma

Gastro Hep Adv. 2024 Feb 1;3(4):506-509. doi: 10.1016/j.gastha.2024.01.013. eCollection 2024.

Authors

Hiroyuki Suzuki^{1

2}, Miwa Sakai¹, Hideki Iwamoto^{1

2

3}, Shigeo Shimose¹, Takashi Niizeki¹, Masahito Nakano¹, Tomotake Shirono¹, Yu Noda¹, Etsuko Moriyama¹, Ryoko Kuromatsu^{1

2}, Hironori Koga^{1

2}, Takumi Kawaguchi¹

Affiliations

¹ Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
² Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Japan.
³ Iwamoto Internal Medicine Clinic, Kitakyushu, Japan.

No abstract available

Publication types

Review